Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer
| Distributed by / for | Direct Rx Dawsonville, GA 30534 |
| NDC | 61919-952-30 |
| Full product label | Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-952-30 |
| Recalling firm | Direct Rx |
| Distribution | GA |
| Quantity | 33 bottles |
| Recall initiated | 2019-04-30 |
| Report date | 2020-10-14 |
| Recall completed | 2020-12-04 |
| Recall number | D-0018-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dawsonville GA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗